• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Acrotech Announces the Publication of Data From a Phase 1 Study of BELEODAQ®

    BUSINESSWIRE

    Acrotech Announces the Publication of Data From a Phase 1 Study of BELEODAQ®

    BUSINESSWIRE

    Deals and M&As this week: Alnylam Pharmaceuticals, Novartis

    PHARMA TECH

    Spectrum Pharmaceuticals sells marketed drugs to Aurobindo subsidiary for up to $300M

    MEDCITY NEWS

    Beleodaq (belinostat) : Spectrum Pharmaceuticals vs. Fresenius Kabi

    PATENT LITIGATION

    FDA Confirms Paragraph IV Patent Challenge of Beleodaq 206256 (Belinostat) Injection

    FDA

    Mundipharma licenses Spectrum`s NHL treatment, picks up Japan affiliate

    FIERCE PHARMA ASIA

    FDA Continues to Lead in Precision Medicine

    FDA VOICE

    PMC Analysis: More Than 20 Percent of FDA`s 2014 Novel New Drug Approvals are Personalized Medicines

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.